H7N9

H7N9
Name	H7N9
Specialty	Infectious disease, Virology

H7N9 H7N9 is an avian-origin influenza A virus subtype identified in humans in 2013 that has caused zoonotic infections associated with high morbidity and mortality. First reported cases involved clusters linked to live poultry markets and prompted responses from organizations such as the World Health Organization, Chinese Center for Disease Control and Prevention, and regional public health authorities in Shanghai, Zhejiang, and Jiangsu. The virus raised concerns among experts from institutions including the Centers for Disease Control and Prevention, World Organisation for Animal Health, and research groups at Harvard University, Johns Hopkins University, and the Pasteur Institute.

Virology and Genetics

H7N9 is an influenza A virus in the Orthomyxoviridae family first characterized by genetic sequencing performed by laboratories at institutions like Peking University, Fudan University, and the Chinese Academy of Sciences. Genetic analyses revealed reassortment events involving gene segments related to avian strains from lineages circulating in Anhui, Guangdong, and the Yangtze River Delta, with polymerase complex mutations such as PB2 E627K identified by teams at University of Hong Kong, Imperial College London, and Wuhan University. Structural studies by groups at Massachusetts Institute of Technology, University of Cambridge, and the National Institute for Biological Standards and Control showed adaptations in hemagglutinin (HA) that affect receptor binding to sialic acid receptors, similar to analyses performed on earlier subtypes like H5N1 and H1N1. Global sequence databases maintained by GISAID, GenBank, and the European Nucleotide Archive house extensive datasets used by virologists at Rockefeller University, Fred Hutchinson Cancer Center, and the Scripps Research Institute to monitor molecular evolution.

Epidemiology and Transmission

Initial epidemiologic investigations led by teams from Shanghai Municipal Center for Disease Control and Prevention, Chinese Center for Disease Control and Prevention, and collaborating centers at WHO Regional Office for the Western Pacific documented exposure links to live poultry markets in cities such as Shanghai, Nanjing, and Hangzhou. Case series published by groups at Peking University First Hospital, Zhejiang University, and Fudan University described sporadic human infections with limited person-to-person transmission, a pattern compared in reviews from Centers for Disease Control and Prevention and World Health Organization. International alerts involved coordination with national agencies like the European Centre for Disease Prevention and Control, Public Health England, and the United States Department of Health and Human Services. Surveillance networks such as those operated by ProMED-mail, FluNet, and academic consortia at University of Melbourne and Osaka University tracked geographic spread and seasonal patterns linked to poultry trade routes and market practices in provinces including Jiangsu, Zhejiang, and Guangxi.

Clinical Presentation and Diagnosis

Clinical descriptions in case reports from Shanghai Public Health Clinical Center, Beijing Ditan Hospital, and international hospitals in Hong Kong and Taipei outlined severe influenza-like illness progressing to viral pneumonia, acute respiratory distress syndrome, and multiorgan failure in some patients, comparable to clinical courses reported for SARS-CoV and MERS-CoV. Diagnostic confirmation relied on real-time RT-PCR assays developed by reference laboratories at Centers for Disease Control and Prevention, WHO Collaborating Centre for Influenza, and regional public health laboratories, with serologic studies conducted by teams at Johns Hopkins University, The University of Tokyo, and Seoul National University Hospital. Imaging findings reported from Fudan University and Peking Union Medical College Hospital showed bilateral infiltrates and consolidation similar to findings in severe cases of H1N1 influenza.

Treatment and Prevention

Clinical management protocols echoed antiviral strategies used for other influenza A infections, with neuraminidase inhibitors studied by researchers at University of Oxford, Karolinska Institutet, and University of California, San Francisco. Antiviral susceptibility testing conducted at CDC and academic centers evaluated resistance markers analogous to those monitored for oseltamivir resistance in prior influenza outbreaks. Vaccine development efforts involved institutions such as Sanofi Pasteur, GlaxoSmithKline, Novavax, and national programs at China National Pharmaceutical Group and academic vaccine centers at Emory University and NIAID, using platforms informed by experiences with seasonal influenza and pandemic preparedness frameworks from WHO. Nonpharmaceutical interventions implemented in affected cities referenced practices applied during outbreaks like 2003 SARS epidemic and 2009 swine flu pandemic.

Animal Reservoirs and Ecology

Ecologic and virologic surveillance conducted by the China Animal Health and Epidemiology Center, Institute of Zoology (Chinese Academy of Sciences), and veterinary departments in provinces including Anhui and Guangdong implicated domestic poultry, particularly chickens and ducks in live markets, as primary reservoirs, with viral gene constellations reflecting reassortment with wild bird lineages found along flyways monitored by groups at BirdLife International, Wetlands International, and ornithology teams at Cornell Lab of Ornithology. Studies by veterinarians at University of Liverpool, Royal Veterinary College, and Utrecht University examined transmission dynamics between backyard farms, commercial operations, and live poultry markets, paralleling ecological assessments used during investigations of H5N1 and H9N2.

Public Health Response and Surveillance

Public health measures coordinated by municipal and national authorities, including closures of live poultry markets in Shanghai, Guangzhou, and Nanjing and culling programs guided by World Organisation for Animal Health recommendations, were informed by modeling and risk assessment from teams at Imperial College London, London School of Hygiene & Tropical Medicine, and Johns Hopkins Bloomberg School of Public Health. International reporting through International Health Regulations (2005), alerts from WHO, and collaborations with OIE and FAO supported diagnostic capacity building at provincial laboratories and enhanced syndromic surveillance systems modeled by European Centre for Disease Prevention and Control and CDC. Ongoing research partnerships involving GISAID, Wellcome Trust, and national research councils continue to monitor viral evolution, vaccine efficacy, and transmission risk in alignment with pandemic preparedness initiatives such as those promoted by Global Health Security Agenda.

Category:Influenza A viruses